Committee Advances Six Bills to Lower Health Care Costs and Increase Price Transparency; PATIENT Act Advanced with Site-Neutral Payments for Outpatient Drugs, PBM Reform and Reauthorization for Health Workforce Programs
May 24, 2023 | |
Committee Advances Six Bills to Lower Health Care Costs and Increase Price Transparency; PATIENT Act Advanced with Site-Neutral Payments for Outpatient Drugs, PBM Reform and Reauthorization for Health Workforce Programs
The House Energy & Commerce (E&C) Health Subcommittee convened a markup of bipartisan bills focused on lowering health care costs, strengthening Pharmacy Benefit Managers (PBMs) oversight, and bringing price transparency to patients. The following bills were advanced to the House. H.R. 1418, the Animal Drug User Fee Amendments of 2023; H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network… (Colocho, May 24, 2023) #340B, #Community Health Centers, #Costs, #Disproportionate Share Hospitals (DSH), #Drug Pricing, #Generic Drugs, #Graduate Medical Education (GME), #Hospitals, #Pharmacy Benefit Managers, #Transparency, #Workforce
